CE Mark Granted for Rapid Bacterial vs Viral Infection Test
The high-throughput host-response assay provides results in approximately 20 minutes to help guide treatment decisions and antimicrobial stewardship.
Read More
Search Results for: point-of-care
CDC Awards $148 Million Contract for Emergency Diagnostic Test Development
The five-year agreement with MRIGlobal aims to enhance laboratory readiness and response for public health emergencies.
Read More
New Blood Test Detects Active and Infectious Tuberculosis
The test identifies antibodies associated with active disease, potentially offering a faster alternative to sputum samples and existing screening methods.
Read More
Co-Diagnostics Joint Venture to Build Molecular Diagnostics Facility in Saudi Arabia
Co-Diagnostics and Arabian Eagle Manufacturing have secured land in Sudair Industrial City, Saudi Arabia, to build a facility for manufacturing molecular diagnostic instruments and assays, supporting regional expansion in the Middle East and North Africa.
Read More
Rapid Molecular Test for Flu and COVID-19 on FINDER Platform Gets FDA Clearance and CLIA-Waiver
The rapid RT-PCR assay runs on the FINDER platform, establishing it as a molecular point-of-care platform with multifunctional capabilities.
Read More